Skip to main content

Table 3 Results of the Six-minute walking test distance of the whole CHF population classified as Euglycemic, IR, and DM

From: Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry

Characteristics Study cohort Euglycemic IR T2D ANOVA F-value Kruskal–Wallis Chi-squared p-value
Heart Rate (bpm) (T0) 68 [60–75] 65 [60–73, 5] 68 [62–77]* 72 [64–76]* 5.5    < 0.01
sPO2 (%) (T0) 97 [96–98] 97 [95–98] 97 [96–98] 97 [96–98] 0.5   0.6
Fatigue Borg Scale (T0) 0 [0–1] 0 [0–0.6] 0 [0–1] 0 [0–1] 1.8
Distance (m) 380 ± 102 397 ± 101 386 ± 107 352 ± 93* 3.6    < 0.01
sPO2 MAX (%) 98 [97–99] 98 [97–99] 98 [97–98] 98 [97–98] 0.8   0.45
sPO2MIN (%) 96 [94–97] 95 [94–97] 96 [94–97] 96]94–97] 0.3   0.8
HR MAX (bpm) 85 [75–97.2] 84 [73–98] 87 [76–97] 85 [77–94] 0.9   0.4
Heart Rate (end) (bpm) 80 [70–90] 76 [68–86.5] 80 [70–93] 81 [72–92] 2.3   0.1
sPO2 (end) (%) 97 [95–98] 97 [95–98] 97 [96–98] 97 [95–98] 0.3   0.7
Fatigue Borg Scale (End) 2 [1–3] 1 [0.5–3] 2 [1–4] 2 [1–3]   3 0.2
  1. *p < 0.05 respect Euglycemic
  2. §p < 0.05 respect IR